Blog

Discover our latest articles and blogs

IV Hydration Side Effects: Why FDA Alerts and 30+ Reports Matter
October 4, 2026

IV Hydration Side Effects: Why FDA Alerts and 30+ Reports Matter

Understand IV hydration risks, what FDA and CDC warnings reveal, and the exact questions to ask before, during, and after an infusion.

Clinic Led Red Light Therapy for Tendonitis: Pain Often Eases in 2–6 Weeks
October 3, 2026

Clinic Led Red Light Therapy for Tendonitis: Pain Often Eases in 2–6 Weeks

Evidence-first, clinic supervised look at red light therapy for tendonitis: why pain often improves in 2–6 weeks, plus dosing, safety, and how it fits rehab.

Clinic Care Beats Home: Red Light Treatment for Stretch Marks
October 2, 2026

Clinic Care Beats Home: Red Light Treatment for Stretch Marks

Clinician review of red and near infrared light for stretch marks: what to expect and when 6–12 clinic sessions outperform home devices.

15–30 Sessions: What Red Light Therapy Before and After Photos Show
October 1, 2026

15–30 Sessions: What Red Light Therapy Before and After Photos Show

Learn what red light therapy changes, when trials found results (15–30 sessions), how to photograph progress, and the key safety thresholds to watch.

When B12 Shots Help: Evidence Based Benefits for Patients
September 30, 2026

When B12 Shots Help: Evidence Based Benefits for Patients

Evidence-first look at who benefits from B12 injections, what they treat, expected timelines and risks, and how nurse led clinics evaluate and follow...

Trial Gains vs IV Risks: Glutathione with Vitamin C Explained
September 29, 2026

Trial Gains vs IV Risks: Glutathione with Vitamin C Explained

Evidence-forward look at how vitamin C recycles glutathione, trial-backed biomarker gains, FDA warnings on injectables, and when to seek supervised IV...

Try Collagen First: Peptides for Joint Pain Backed by 4 Trials
September 28, 2026

Try Collagen First: Peptides for Joint Pain Backed by 4 Trials

Hydrolyzed collagen shows modest joint pain relief in 8–12 weeks. Injectable peptides lack human trials and should be used only with clinician supervision.

Results in 8–12 Weeks: Clinician Take on CJC-1295 and Ipamorelin
September 27, 2026

Results in 8–12 Weeks: Clinician Take on CJC-1295 and Ipamorelin

Clinician summary of CJC-1295 and ipamorelin: human PK/PD evidence, benefits, dosing, safety, and how supervised clinics begin care.

Red Light Hair Growth: Proven Gains in 12–26 Weeks, Clinician Led Care
September 26, 2026

Red Light Hair Growth: Proven Gains in 12–26 Weeks, Clinician Led Care

An evidence-first look at red light hair growth: what trials show, realistic 12–26 week timelines, who should avoid it, and clinician led treatment options.